Latest stories on GYRE
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire56 · neutralgeneral
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Business Insider56 · neutralgeneral
Gyre Therapeutics Highlights Capital-Efficient Global Development Strategy
TipRanks56 · neutralproduct/pr
GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
Gyre Therapeutics unveils capital-efficient global development strategy
TipRanks63 · neutralproduct/pr
GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
Gyre Therapeutics GAAP EPS of -$0.12 misses by $0.06, revenue of $29.1M beats by $2.61M
Seeking Alpha47 · neutralearnings
Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
StockTitan53 · neutralearnings
GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
Gyre Therapeutics Appoints Three New Members to its Board of Directors
Business Insider55 · neutralgeneral
8-K/A - GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
GYRE THERAPEUTICS, INC. (GYRE) files 8-K
SEC 8-K50 · neutralgeneral
Gyre Therapeutics Updates Post-Cullgen Acquisition Growth Strategy
TipRanks63 · neutralm&a
[Form 4] GYRE THERAPEUTICS, INC. Insider Trading Activity
StockTitan SEC50 · neutralgeneral